Spyre Theraputics

BiotechnologySeries BAustin, USspyre.com

Latest round

Series B

Last raised

Mar 2015

Total raised

$56M

Investors

12

About Spyre Theraputics

Founded in 2013 and based in Texas, US, Spyre Theraputics, Inc. operates as a biotechnology technology company that develops and provides human enzyme therapeutics to treat patients suffering from rare genetic diseases and cancer. Spyre Therapeutics is dedicated to advancing the treatment landscape for Inflammatory Bowel Disease (IBD) through its therapeutic approaches like antibodies and rational therapeutic combinations. The company improves outcomes for patients with conditions like ulcerative colitis (UC) and Crohn’s disease (CD). Spyre's portfolio includes novel monoclonal antibody candidates like SPY001 and SPY002, designed with extended half-lives and targeting specific mechanisms of IBD pathology.

Who invested in Spyre Theraputics

12 investors across 2 rounds

See all investors in Spyre Theraputics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Mar 10, 2015

    Amount

    $44M

    Investors

    Locked

  2. Series A

    Feb 3, 2014

    Amount

    $12M

    Investors

    Locked

Questions about Spyre Theraputics

Who invested in Spyre Theraputics?

Spyre Theraputics has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Spyre Theraputics raised?

Spyre Theraputics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Spyre Theraputics last raise money?

Spyre Theraputics's most recent round on record is a Series B, in Mar 2015.

What does Spyre Theraputics do?

Founded in 2013 and based in Texas, US, Spyre Theraputics, Inc.

Where is Spyre Theraputics headquartered?

Spyre Theraputics is headquartered in Austin, US.

Which VCs invest in companies like Spyre Theraputics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Spyre Theraputics's stage. Their profiles are linked below.

Raising like Spyre Theraputics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.